Several groups have reported that genetically reducing NFE2L2 in animal models increases oxidative stress and inflammation, replicates gene alteration in gene expression typical of AD brains and exacerbates cognitive deficits [47,48,49]. This evidence concerns the gene NFE2L2 and Alzheimer disease.